Gland Pharma vs Nifty 50: Share Price Performance Compared

Gland Pharma vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Gland Pharma trades on the NSE under the symbol GLAND, and its 1M return of +15.33% compares with the Nifty 50's -1.44% over the same period.

The Gland Pharma vs Nifty 50 comparison matters because Gland Pharma is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Gland Pharma share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.

Click Here – Get Free Investment Predictions

Gland Pharma vs Nifty 50: Performance at a Glance

The table below sets out Gland Pharma vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 31 August 2026.

Time Frame	Gland Pharma Return	Nifty 50 Return	Difference
1 Month	+15.33%	-1.44%	+16.77% pp
3 Months	+25.92%	+2.78%	+23.14% pp
6 Months	+60.83%	-3.35%	+64.18% pp
1 Year	+54.27%	-2.41%	+56.68% pp
3 Years	+63.25%	+23.65%	+39.61% pp
5 Years	-26.0% (Gland Pharma)	+40.73% (Nifty 50)	-66.73% pp

On the Gland Pharma vs Nifty 50 scorecard, Gland Pharma has stayed ahead of the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.

Check the Univest Screener for live Gland Pharma and Nifty 50 data

Why the Gland Pharma vs Nifty 50 Gap Exists

Gland Pharma's stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Gland Pharma vs Nifty 50 return table above.

A second factor behind the Gland Pharma vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Gland Pharma's price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.

Download the Univest iOS App or Univest Android App to track Gland Pharma and Nifty 50 live on the go.

Gland Pharma vs Nifty 50: Has Gland Pharma Beaten the Benchmark?

Gland Pharma has beaten the Nifty 50 over the past year, gaining +54.27% against the index's -2.41% over the same period. Over the longer term the index has closed some of that gap.

Risks of the Gland Pharma vs Nifty 50 Comparison

Reading too much into a Gland Pharma vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Gland Pharma carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 1,573.60 to Rs 3,039.80 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Gland Pharma vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Gland Pharma vs Nifty 50 record should factor in Gland Pharma's volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Has Gland Pharma outperformed the Nifty 50 in the last year?

Ans. Yes. Gland Pharma gained +54.27% over the past year while the Nifty 50 returned -2.41% over the same period, based on NSE closing prices to 31 August 2026.

How does Gland Pharma vs Nifty 50 look over 5 years?

Ans. Over five years Gland Pharma has returned -26.0% compared with the Nifty 50's +40.73%, so in the Gland Pharma vs Nifty 50 comparison the index has been ahead over this longer horizon.

What is the Gland Pharma share price today compared to Nifty 50?

Ans. Gland Pharma share price stood at Rs 2,886.50 on NSE, while the Nifty 50 traded at 24,031.60 based on the same closing data window.

What is the 52-week high and low of Gland Pharma?

Ans. Gland Pharma's 52-week high is Rs 3,039.80 and its 52-week low is Rs 1,573.60, based on NSE data.

Why does Gland Pharma show bigger price swings than the Nifty 50?

Ans. Gland Pharma carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Gland Pharma's price more sharply than the diversified index, a key reason the Gland Pharma vs Nifty 50 return gap varies across time frames.

Is Gland Pharma a good long-term investment compared to a Nifty 50 index fund?

Ans. Gland Pharma's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Gland Pharma vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.